Bessemer Group’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Buy |
34,610
+30
| +0.1% | +$983 | ﹤0.01% | 604 |
|
|
2025
Q1 | $1.12M | Sell |
34,580
-5,345
| -13% | -$172K | ﹤0.01% | 663 |
|
|
2024
Q4 | $1.22M | Sell |
39,925
-1,700
| -4% | -$51.9K | ﹤0.01% | 735 |
|
|
2024
Q3 | $1.17M | Buy |
41,625
+5,989
| +17% | +$168K | ﹤0.01% | 755 |
|
|
2024
Q2 | $811K | Buy |
35,636
+136
| +0.4% | +$3.1K | ﹤0.01% | 707 |
|
|
2024
Q1 | $1.08M | Buy |
35,500
+8,120
| +30% | +$247K | ﹤0.01% | 665 |
|
|
2023
Q4 | $977K | Buy |
27,380
+9,280
| +51% | +$331K | ﹤0.01% | 664 |
|
|
2023
Q3 | $793K | Buy |
18,100
+8,148
| +82% | +$357K | ﹤0.01% | 680 |
|
|
2023
Q2 | $491K | Buy |
+9,952
| New | +$491K | ﹤0.01% | 818 |
|
|
2022
Q4 | – | Sell |
-62
| Closed | -$2K | – | 1881 |
|
|
2022
Q3 | $2K | Buy |
+62
| New | +$2K | ﹤0.01% | 1894 |
|
|
2020
Q3 | – | Sell |
-37,200
| Closed | -$1.67M | – | 1359 |
|
|
2020
Q2 | $1.67M | Hold |
37,200
| – | – | 0.01% | 547 |
|
|
2020
Q1 | $1.25M | Sell |
37,200
-15,900
| -30% | -$534K | 0.01% | 540 |
|
|
2019
Q4 | $1.73M | Sell |
53,100
-43,300
| -45% | -$1.41M | 0.01% | 608 |
|
|
2019
Q3 | $2.4M | Buy |
96,400
+12,700
| +15% | +$317K | 0.01% | 469 |
|
|
2019
Q2 | $2.5M | Buy |
83,700
+13,900
| +20% | +$415K | 0.01% | 463 |
|
|
2019
Q1 | $1.87M | Buy |
69,800
+62,200
| +818% | +$1.67M | 0.01% | 475 |
|
|
2018
Q4 | $233K | Buy |
+7,600
| New | +$233K | ﹤0.01% | 950 |
|